Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Bio Feb 8, 2024 07:30AM
Salona Global Medical Device Corporation Releases Audited Fiscal Year-end Financials; Highlights Significant Revenue, Gross Profit Growth and Vertical Integration From Acquisitions; Announces Timing a Jun 1, 2022 09:17AM
Sugarmade (SGMD) Issues Shareholder Letter and Corporate Update May 2, 2022 08:30AM
Salona Global Medical Device Corporation Posts 52% Quarterly Revenue Growth and 44% Quarterly Gross Profit Growth for the Fiscal Fourth Quarter Ending February 28, 2022; Provides a Business Update Inc Mar 31, 2022 07:30AM